Showing results (101-110 of 148) with videos related to

Sort By:
Pageof 15
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 1, 2008
Induction of both CD8+ and CD4+ T-cell-mediated responses in colorectal cancer patients by colon antigen-1Cristina Maccalli, Veronica Di Cristanziano, Valentina Fodale, et al.
Integrative Cancer Therapies|May 7, 2019
A Pilot Low-Inflammatory Dietary Intervention to Reduce Inflammation and Improve Quality of Life in Patients With Familial Adenomatous Polyposis: Protocol Description and Preliminary ResultsPatrizia Pasanisi, Manuela Gariboldi, Paolo Verderio, et al.
Cancer Research|May 18, 2012
Modulation of microenvironment acidity reverses anergy in human and murine tumor-infiltrating T lymphocytesArianna Calcinotto, Paola Filipazzi, Matteo Grioni, et al.
Cancer Research|March 23, 2005
Reconstitution of human telomerase reverse transcriptase expression rescues colorectal carcinoma cells from in vitro senescence: evidence against immortality as a constitutive trait of tumor cellsPiero Dalerba, Cristiana Guiducci, Pietro Luigi Poliani, et al.
Plos One|April 22, 2009
High levels of exosomes expressing CD63 and caveolin-1 in plasma of melanoma patientsMariantonia Logozzi, Angelo De Milito, Luana Lugini, et al.
Clinical and Translational Medicine|June 29, 2021
Integrated transcriptional-phenotypic analysis captures systemic immunomodulation following antiangiogenic therapy in renal cell carcinoma patientsDarawan Rinchai, Elena Verzoni, Veronica Huber, et al.
The Journal of Investigative Dermatology|April 9, 2010
Heterogeneous phenotype of human melanoma cells with in vitro and in vivo features of tumor-initiating cellsMichela Perego, Monica Tortoreto, Gabrina Tragni, et al.
Hepatology (Baltimore, Md.)|April 18, 2018
Hepatocellular Carcinoma Is Associated With Gut Microbiota Profile and Inflammation in Nonalcoholic Fatty Liver DiseaseFrancesca Romana Ponziani, Sherrie Bhoori, Chiara Castelli, et al.
The Lancet. Oncology|August 17, 2012
Ipilimumab and fotemustine in patients with advanced melanoma (NIBIT-M1): an open-label, single-arm phase 2 trialAnna Maria Di Giacomo, Paolo A Ascierto, Lorenzo Pilla, et al.
Frontiers in Immunology|January 19, 2026
SPACA6-hosted miR-99b~125a~let-7e cluster shapes melanoma resistance by modulating mTOR-mediated immunosuppressionViviana Vallacchi, Gianpiero Lupoli, Eriomina Shahaj, et al.
Pageof 15